Lifevantage Corporation
LFVN
$5.15
$0.010.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -25.20% | -27.79% | 0.73% | 12.64% | 21.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.20% | -27.79% | 0.73% | 12.64% | 21.13% |
| Cost of Revenue | -17.47% | -3.58% | 2.68% | 10.41% | 9.25% |
| Gross Profit | -27.01% | -33.64% | 0.25% | 13.21% | 24.31% |
| SG&A Expenses | -24.28% | -29.63% | 1.12% | 16.39% | 19.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.89% | -24.29% | 1.45% | 15.09% | 17.44% |
| Operating Income | -56.13% | -93.55% | -11.75% | -26.19% | 109.57% |
| Income Before Tax | -60.38% | -84.69% | -13.07% | -11.62% | 117.60% |
| Income Tax Expenses | -58.59% | -63.45% | -88.56% | -68.92% | 170.99% |
| Earnings from Continuing Operations | -60.75% | -89.18% | 18.02% | 50.11% | 109.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.75% | -89.18% | 18.02% | 50.11% | 109.16% |
| EBIT | -56.13% | -93.55% | -11.75% | -26.19% | 109.57% |
| EBITDA | -48.68% | -77.02% | -14.52% | -22.01% | 71.65% |
| EPS Basic | -61.60% | -89.56% | 15.79% | 49.20% | 110.49% |
| Normalized Basic EPS | -58.91% | -93.55% | -14.72% | -12.08% | 118.94% |
| EPS Diluted | -58.50% | -89.47% | 21.43% | 47.47% | 100.00% |
| Normalized Diluted EPS | -55.86% | -93.04% | -13.85% | -13.36% | 112.32% |
| Average Basic Shares Outstanding | 2.23% | 3.54% | 1.94% | 0.57% | -0.60% |
| Average Diluted Shares Outstanding | -4.81% | -3.28% | 0.95% | 2.03% | 2.42% |
| Dividend Per Share | 12.50% | 12.50% | 12.50% | 12.50% | 14.29% |
| Payout Ratio | 1.90% | 9.58% | -0.03% | -0.26% | -0.46% |